Abstract | BACKGROUND/AIMS: METHODS: RESULTS: 20 patients (13.6%) had coexisting gastric varices at baseline (GOV+). 10 of those each received either band ligation or propranolol, respectively. During follow-up (34.4 +/- 18.9 months) new gastric varices occurred in 2/75 (2.7%, ligation) and 4/77 (5.2%, propranolol) patients, respectively. One patient with newly developed gastric varices bled ( propranolol group). GOV+ patients had a better baseline liver function and overall survival. Bleeding incidence did not differ significantly between GOV+ and GOV- patients (3-year actuarial risk: 20.0 +/- 10.6% (GOV+), 38.1 +/- 4.4% (GOV-), p = 0.195). Among GOV+ patients, bleeding occurred in 3/10 patients of the propranolol group and in 0/10 in the ligation group (p = 0.038). CONCLUSION:
|
Authors | Michael Schepke, Erwin Biecker, Beate Appenrodt, Joerg Heller, Tilman Sauerbruch |
Journal | Digestion
(Digestion)
Vol. 80
Issue 3
Pg. 165-9
( 2009)
ISSN: 1421-9867 [Electronic] Switzerland |
PMID | 19776579
(Publication Type: Journal Article, Multicenter Study)
|
Copyright | Copyright 2009 S. Karger AG, Basel. |
Topics |
- Adolescent
- Adult
- Aged
- Esophageal and Gastric Varices
(complications, pathology, surgery)
- Female
- Gastrointestinal Hemorrhage
(etiology, prevention & control)
- Humans
- Kaplan-Meier Estimate
- Ligation
- Liver Cirrhosis
(complications)
- Male
- Middle Aged
- Young Adult
|